Modelling Therapy Resistance for the Identification of Treatment-Refractory Cell Population(s) in Human Glioblastoma

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/cjn.2016.330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Cancer Research
Cancer ResearchOncology
2014English

Mechanisms of Cell Resistance in Glioblastoma Multiforme

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2010English

Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report

Integrative Cancer Science and Therapeutics
2015English

Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy

British Journal of Haematology
Hematology
2020English

Cell Death-Based Treatment of Glioblastoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy

Journal of Clinical Medicine
2019English

Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma

Clinical and Translational Immunology
AllergyImmunologyNursing
2019English

Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Knockdown of Arsenic Resistance Protein 2 Inhibits Human Glioblastoma Cell Proliferation Through the MAPK/ERK Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy